Shields LBE - Search Results

1

Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.

Dashti SR, Kadner RJ, Folley BS, Sheehan JP, Han DY, Kryscio RJ, Carter MB, Shields LBE, Plato BM, La Rocca RV, Spalding AC, Yao TL, Fraser JF. Dashti SR, et al. Among authors: shields lbe. J Neurosurg. 2022 Apr 15;137(6):1676-1686. doi: 10.3171/2022.2.JNS212006. Print 2022 Dec 1. J Neurosurg. 2022. PMID: 35426830 Clinical Trial.

2

Tumor histology and location predict deep nuclei toxicity: Implications for late effects from focal brain irradiation.

Plaga A, Shields LB, Sun DA, Vitaz TW, Spalding AC. Plaga A, et al. Med Dosim. 2012 Autumn;37(3):276-9. doi: 10.1016/j.meddos.2011.10.002. Epub 2011 Dec 19. Med Dosim. 2012. PMID: 22189027

3

Intrathecal treatment of cerebral vasospasm.

Zhang YP, Shields LB, Yao TL, Dashti SR, Shields CB. Zhang YP, et al. J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1201-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.005. Epub 2012 May 30. J Stroke Cerebrovasc Dis. 2013. PMID: 22651990 Review.

4

Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.

Shields LB, Kadner R, Vitaz TW, Spalding AC. Shields LB, et al. Radiat Oncol. 2013 Apr 25;8:101. doi: 10.1186/1748-717X-8-101. Radiat Oncol. 2013. PMID: 23618500 Free PMC article.

5

Improvement of therapeutic index for brain tumors with daily image guidance.

Shields LB, Coons JM, Dedich C, Ragains M, Scalf K, Vitaz TW, Spalding AC. Shields LB, et al. Radiat Oncol. 2013 Dec 2;8:283. doi: 10.1186/1748-717X-8-283. Radiat Oncol. 2013. PMID: 24295338 Free PMC article.

6

BAER suppression during posterior fossa dural opening.

Shields CB, Shields LB, Jiang YD, Yao T, Zhang YP, Sun DA. Shields CB, et al. Surg Neurol Int. 2015 Apr 9;6:57. doi: 10.4103/2152-7806.154775. eCollection 2015. Surg Neurol Int. 2015. PMID: 25883849 Free PMC article.

7

Quantifying isocenter measurements to establish clinically meaningful thresholds.

Denton TR, Shields LB, Howe JN, Spalding AC. Denton TR, et al. J Appl Clin Med Phys. 2015 Mar 8;16(2):5183. doi: 10.1120/jacmp.v16i2.5183. J Appl Clin Med Phys. 2015. PMID: 26103187 Free PMC article.

8

Heterogeneity correction for intensity-modulated frameless SRS in pituitary and cavernous sinus tumors: a retrospective study.

Shields LB, Bond C, Odom A, Sun DA, Spalding AC. Shields LB, et al. Radiat Oncol. 2015 Sep 17;10:193. doi: 10.1186/s13014-015-0500-y. Radiat Oncol. 2015. PMID: 26377815 Free PMC article.

9

Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.

Shields LB, Shelton BJ, Shearer AJ, Chen L, Sun DA, Parsons S, Bourne TD, LaRocca R, Spalding AC. Shields LB, et al. Radiat Oncol. 2015 Oct 31;10:222. doi: 10.1186/s13014-015-0527-0. Radiat Oncol. 2015. PMID: 26520780 Free PMC article.

10

Guidelines for treatment naming in radiation oncology.

Denton TR, Shields LB, Hahl M, Maudlin C, Bassett M, Spalding AC. Denton TR, et al. J Appl Clin Med Phys. 2015 Nov 7;17(2):123-138. doi: 10.1120/jacmp.v17i2.5953. J Appl Clin Med Phys. 2015. PMID: 27074449 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page